Wednesday, 22 July 2026
OTC CGM approved for kids, New sunscreen ingredient approved, Concerns over drug payment transparency
- 01
FDA Approves First Over-the-Counter CGM for Children
The US Food and Drug Administration (FDA) has approved the first over-the-counter continuous glucose monitor (CGM) specifically for children. This approval marks a significant advancement in diabetes management for pediatric patients. The availability of this device may enhance glucose monitoring options for families and healthcare providers. This development is particularly relevant for clinicians involved in the care of children with diabetes.
via JAMA
- 02
FDA Approves New Sunscreen Ingredient Bemotrizinol
The US Food and Drug Administration (FDA) has approved bemotrizinol as a new active ingredient in sunscreen, marking the first addition to the list since the 1990s. This regulatory change may influence dermatological practices and patient recommendations in Australia.
via JAMA
- 03
Experts criticise lack of progress on drug payment transparency
Experts have expressed concern over the lack of progress in improving transparency regarding payments from drug companies to doctors. Government-led workshops held earlier this year did not reassure stakeholders about the commitment to mandatory reporting of these payments. The 2020 Cumberledge review, which followed several drug and medical device scandals, recommended such reporting to enhance accountability. However, the lead researcher of the review described the current inaction from the government as "appalling," highlighting ongoing ethical concerns.
via BMJ
- 04
DRC Faces 17th Ebola Outbreak in 50 Years Amid Mistrust
The Democratic Republic of Congo (DRC) has experienced 17 Ebola outbreaks in the past 50 years, with the latest declared a public health emergency by the World Health Organization on 17 May. As of 8 July, the outbreak has resulted in 1759 suspected cases and 600 deaths across Ituri and Nord-Kivu provinces. The recurring nature of these outbreaks raises questions about the underlying structural vulnerabilities and the lack of trust in health systems. This situation has implications for global health preparedness and response strategies.
via BMJ
- 05
AI-Based OCT System Evaluated for Diabetic Retinopathy Screening
A prospective validation study and a randomized clinical trial have assessed an artificial intelligence–optical coherence tomography (OCT) system for detecting diabetic macular edema. This evaluation took place within a diabetic retinopathy screening pathway in clinical settings in Hong Kong. The findings could influence future practices in managing diabetic retinopathy.
via JAMA
- 06
Accreditors Commit to Enhanced Nutrition Education in Medical Training
The US Department of Health and Human Services announced that eight accrediting bodies and medical organizations will increase nutrition education requirements in medical education. This initiative aims to improve the competency of future healthcare providers. The commitment reflects a growing recognition of the importance of nutrition in patient care.
via JAMA
MDDR is a news digest for medical professionals. It is not medical advice and should not be relied on for clinical decision-making.